China’s CROs Make Connection in S.D. #BiocomCRO

PHARMA: THEY’RE PART OF GROWING BIOTECH RELATIONSHIP China’s CROs Make Connection in S.D. By Jared Whitlock Sunday, June 10, 2018   San Diego — In San Diego, the last decade gave rise to biotechs farming out work to contract research organizations, or CROs. It’s an industry increasingly colored by China. In recent years, Chinese-linked CROs, led by […]

Read More

Catalent Biologics Supports InterveXion on New Treatment for Methamphetamine Users

SOMERSET, N.J. – May 31, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today welcomed the news that InterveXion has enrolled the first patient in STAMPOUT, the first trial in methamphetamine users of the first-in-class anti-methamphetamine antibody IXT-m200. STAMPOUT will […]

Read More

Rapid Novor is developing a non-invasive, blood-based test for the multiple myeloma patients’ Minimal Residual Disease (MRD) assessment and monitoring

Have you just developed a new technology that potential partners need to discover? Share it with us and describe how it can be used to further research, drug development, and/or innovation. Our company Rapid Novor is developing a non-invasive, blood-based test for the multiple myeloma patients’ Minimal Residual Disease (MRD) assessment and monitoring. We use the mass […]

Read More